Cardiologic Department, Glostrup Hospital, Copenhagen, 2600 Glostrup, Denmark.
Br J Clin Pharmacol. 1974 Jun;1(3):197-202. doi: 10.1111/j.1365-2125.1974.tb00236.x.
1 ST-91, 2-(2,6-diethylphenylamino)-2-imidazoline hydrochloride produces in animal experiments bradycardia, and in larger doses, also hypertension, due to α-sympathomimetic activity and probable central sympathetic inhibition. 2 The effects of ST-91, after oral administration, were studied in 10 healthy volunteers. A dose-dependent, significant decrease of the heart rate was observed. On average the resting heart rate was reduced by 11-19 beats/min (15-29%). During exercise the decrease of the heart rate was less pronounced. After the largest dose there was a fall of the systolic blood pressure during exercise averaging at 14-15 mmHg (11-12%). Otherwise the blood pressure remained unchanged. 3 Eight out of the 10 test-subjects complained of hair-raising and goose-flesh after all doses, due to the α-sympathomimetic effect of the drug. No toxic effects were observed.
ST-91,2-(2,6-二乙基苯氨基)-2-咪唑啉盐酸盐在动物实验中产生心动过缓,并且在较大剂量下也会由于 α-拟交感神经活性和可能的中枢交感神经抑制而导致高血压。
在 10 名健康志愿者中研究了 ST-91 口服后的作用。观察到剂量依赖性的心率显著降低。平均而言,静息心率降低了 11-19 次/分钟(15-29%)。在运动过程中,心率的下降不那么明显。在最大剂量后,运动期间收缩压平均下降 14-15 mmHg(11-12%)。否则血压保持不变。
由于药物的 α-拟交感神经作用,所有剂量后 10 名测试对象中有 8 名出现毛发竖起和鸡皮疙瘩的现象。未观察到毒性作用。